Literature DB >> 20937924

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.

Doron Garfinkel1, Derelie Mangin.   

Abstract

BACKGROUND: Polypharmacy and inappropriate medication use is a problem in elderly patients, who are more likely to experience adverse effects from multiple treatments and less likely to obtain the same therapeutic benefit as younger populations. The Good Palliative-Geriatric Practice algorithm for drug discontinuation has been shown to be effective in reducing polypharmacy and improving mortality and morbidity in nursing home inpatients. This study reports the feasibility of this approach in community-dwelling older patients.
METHODS: The Good Palliative-Geriatric Practice algorithm was applied to a cohort of 70 community-dwelling older patients to recommend drug discontinuations. Success rates of discontinuation, morbidity, mortality, and changes in health status were recorded.
RESULTS: The mean (SD) age of the 70 patients was 82.8 (6.9) years. Forty-three patients (61%) had 3 or more and 26% had 5 or more comorbidities. The mean follow-up was 19 months. Participants used a mean (SD) of 7.7 (3.7) medications. Protocol indicated that discontinuation was recommended for 311 medications in 64 patients (58% of drugs; mean [SD], 4.4 [2.5] drugs per patient overall, 4.9 per patient who had discontinuation). Of the discontinued drug therapies, 2% were restarted because of recurrence of the original indication. Taking nonconsent and failures together, successful discontinuation was achieved in 81%. Ten elderly patients (14%) died after a mean follow-up of 13 months, with the mean age at death of 89 years. No significant adverse events or deaths were attributable to discontinuation, and 88% of patients reported global improvement in health.
CONCLUSIONS: It is feasible to decrease medication burden in community-dwelling elderly patients. This tool would be suitable for larger randomized controlled trials in different clinical settings.

Entities:  

Mesh:

Year:  2010        PMID: 20937924     DOI: 10.1001/archinternmed.2010.355

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  158 in total

Review 1.  Initiation of statin therapy: are there age limits?

Authors:  Dipan A Desai; Sammy Zakaria; Pamela Ouyang
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

Review 2.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

3.  30th George Swift Lecture: generalism in undergraduate medical education - what's next?

Authors:  Tony Kendrick
Journal:  Br J Gen Pract       Date:  2012-06       Impact factor: 5.386

4.  Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

Authors:  K P G M Hurkens; C Mestres-Gonzalvo; H A J M de Wit; P H M van der Kuy; R Janknegt; F Verhey; J M G A Schols; C D A Stehouwer; B Winkens; W Mulder
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 5.  Routine deprescribing of chronic medications to combat polypharmacy.

Authors:  Doron Garfinkel; Birkan Ilhan; Gulistan Bahat
Journal:  Ther Adv Drug Saf       Date:  2015-12

6.  Wise therapeutic decisions for older patients.

Authors:  Thomas Frühwald
Journal:  Wien Med Wochenschr       Date:  2016-04

7.  Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care.

Authors:  Eladio Fernández-Liz; Pere Vivó Tristante; Antonio Aranzana Martínez; Maria Estrella Barceló Colomer; Josep Ossó Rebull; Maria Josep López Dolcet
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

8.  Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Authors:  Alessandro Galazzi; Maura Lusignani; Maria Teresa Chiarelli; Pier Mannuccio Mannucci; Carlotta Franchi; Mauro Tettamanti; Emily Reeve; Alessandro Nobili
Journal:  Int J Clin Pharm       Date:  2016-03-07

Review 9.  The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

Authors:  Laura K Triantafylidis; Chelsea E Hawley; Laura P Perry; Julie M Paik
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

10.  Pharmacological management of co-morbid conditions at the end of life: is less more?

Authors:  S McLean; B Sheehy-Skeffington; N O'Leary; A O'Gorman
Journal:  Ir J Med Sci       Date:  2012-07-29       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.